- 関
- Follitropin
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 卵巣過剰刺激症候群の予防 prevention of ovarian hyperstimulation syndrome
- 2. 排卵誘発の概要 overview of ovulation induction
English Journal
- Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line.
- Olsson H1, Sandström R, Grundemar L.
- Journal of clinical pharmacology.J Clin Pharmacol.2014 Nov;54(11):1299-307. doi: 10.1002/jcph.328. Epub 2014 May 21.
- Pharmacokinetic and pharmacodynamic properties of a novel recombinant follicle-stimulating hormone (rFSH) preparation (FE 999049), expressed by a human cell line (PER.C6), was compared with an rFSH preparation (follitropin α) expressed by a Chinese hamster ovary (CHO) cell line in healthy pituitary
- PMID 24800998
- Ala307Thr and Asn680Ser Polymorphisms of FSHR Gene in Human Reproduction Outcomes.
- Trevisan CM1, Peluso C, Cordts EB, de Oliveira R, Christofolini DM, Barbosa CP, Bianco B.
- Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.Cell Physiol Biochem.2014 Oct 9;34(5):1527-1535. [Epub ahead of print]
- Background/Aims: It is known that some markers of ovarian stimulation can help to personalize the treatment, adjusting the dose of exogenous rFSH, thus preventing excessive wear of the patient. We aimed to evaluate Ala307Thr and Asn680Ser genotypes of the FSHR gene in infertile women and correlate t
- PMID 25322982
- Effect of Piroxicam on ART Outcome: A Pilot Study.
- Sohrabvand F1, Haghollahi F2, Maasomi M2, Shariat M3.
- International journal of fertility & sterility.Int J Fertil Steril.2014 Oct;8(3):243-8. Epub 2014 Nov 1.
- BACKGROUND: One of the most important factors affecting success rates in assisted reproductive techniques (ART) besides the number of oocytes retrieved and high quality embryos derived from them is the technical aspects of embryo transfer. It seems that pretreatement with uterine relaxants can be he
- PMID 25379151
Japanese Journal
- Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols
- ペン型遺伝子組換えヒト卵胞刺激ホルモン(ゴナールエフ皮下注ペン^【○!R】 : rFSH)導入による安全で有効な排卵誘発法
- 現代産婦人科 = Modern trends in obstetrics & gynecology 61(1), 73-77, 2012-12-27
- NAID 10031134689
- 排卵誘発剤の在宅自己注射を行う女性の自己管理状況を測定する質問紙の開発
Related Links
- hMG/rFSHの排卵誘発剤を生理開始3日目から投与。投与する注射の種類は数種類あり、その種類や注射の単位量は個人により異なる。投与量を調整することで採卵数をコントロールでき、クロミフェンを使用しないため子宮内膜への影響は ...
- rFSH製剤 注射 FSH作用(FSH:LH=1:0) GnRHアゴニスト製剤 ショート法やロング法に用いる製剤で、スプレキュアを使用します。 良い点 考慮すべき点 ・排卵のスケジュールコントロールが最適な方法。 ・下垂体回復まで時間がかかる ...
Related Pictures
★リンクテーブル★
[★]
- 英
- follitropin
- 同
- rFSH
- 関
- 卵胞刺激ホルモン